Outreach Coronavirus information

COVID-19 Pandemic

All people monitored by the HMDS Outreach service have a higher risk of COVID-19 illness as a result of their blood disorder. Some people on HMDS Outreach service are extremely vulnerable.

Please check your risk status and relevant guidance for your specific disorder through the links below:

Chronic myeloid leukaemia (CML)

B-lymphoproliferative disorders (includes the following:  “B-cell chronic lymphocytic leukaemia (B-cell CLL)”; “CD5+ LPD –intermediate phenotype”; “CD5-negative B-cell LPD NOS”; “Monoclonal B-cell lymphocytosis (CLL phenotype)”; “MYD88 mutated B-cell lymphoproliferative disorder”; or “Systemic marginal zone lymphoma”)

Monoclonal Gammopathy of Undetermined Significance (MGUS)

If you are continuing to work or have any face-to-face appointments, please let your employer or service provider know about your risk category as they may need to make special arrangements.

If you receive a pack or one has already arrived during the lockdown, please contact your GP practice to see if they can collect the blood samples safely. In most cases it is not urgent to have the blood samples collected immediately. If you would prefer to avoid having the blood samples taken at the moment, please keep hold of the pack until social distancing restrictions are removed. If you are unsure, please contact us to check if you need to get the samples taken.

If you have an email address, please email leedsth-tr.HMDSOutreach@nhs.net so that we can contact you rapidly if the situation changes. You can also call on 0113 206 7851 and ask to speak to Vicky or Andy but please be aware that call volumes are high at the moment.

For questions about COVID-19 symptoms please go to https://111.nhs.uk or call 111. For the latest NHS information please go to https://www.nhs.uk/conditions/coronavirus-covid-19/ or https://www.nhs.uk/conditions/coronavirus-covid-19/advice-for-people-at-high-risk/

Further support may also be available through https://www.myeloma.org.uk (for MGUS patients), https://www.cllsupport.org.uk (for MBL/CLL patients), or https://www.macmillan.org.uk (general advice)

Updated:25-June-2020.